A clinical review of bleomycin--a new antineoplastic agent

Cancer. 1973 Apr;31(4):903-14. doi: 10.1002/1097-0142(197304)31:4<903::aid-cncr2820310422>3.0.co;2-n.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Adenocarcinoma / drug therapy
  • Antibiotics, Antineoplastic / therapeutic use*
  • Bleomycin / administration & dosage
  • Bleomycin / adverse effects
  • Bleomycin / therapeutic use
  • Bone Marrow / drug effects
  • Bone Neoplasms / drug therapy
  • Carcinoma / drug therapy
  • Carcinoma, Squamous Cell / drug therapy
  • Clinical Trials as Topic
  • Female
  • Fever / chemically induced
  • Head and Neck Neoplasms / drug therapy
  • Humans
  • Leukemia / drug therapy
  • Lung Diseases / chemically induced
  • Lymphoma / drug therapy
  • Melanoma / drug therapy
  • Multiple Myeloma / drug therapy
  • Sarcoma / drug therapy
  • Skin / drug effects
  • Urinary Bladder Neoplasms / drug therapy
  • Urogenital Neoplasms / drug therapy

Substances

  • Antibiotics, Antineoplastic
  • Bleomycin